Accelerated Pharma IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Accelerated Pharma | ACCP - NASDAQ |
$4.00-$6.00 | $0.00 | $0.00 | Postponed | 7/21/2017 |
| Rodman & Renshaw, Joseph Gunnar & Co. | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2016-10-11 Terms Changed 2016-12-12 Terms revised 2016-12-12 Updated Prospectus 2017-03-28 Underwriters Added 2017-04-26 Updated Prospectus 2017-07-12 Updated Prospectus 2017-07-12 | ||||||
About Accelerated Pharma (adapted from Accelerated Pharma prospectus):
They are a clinical stage biopharmaceutical company focused on utilizing our genomic technology to (i) enhance the development of pre-existing pharmaceutical products for the treatment of various cancer indications, (ii) prospectively identify patients that may respond to such pharmaceutical products and (iii) commercialize such pharmaceutical products for sale in various markets.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical stage biopharmaceutical company focused on utilizing our genomic technology to (i) enhance the development of pre-existing pharmaceutical products for the treatment of various cancer indications, (ii) prospectively identify patients that may respond to such pharmaceutical products and (iii) commercialize such pharmaceutical products for sale in various markets.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "ACCP" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.